Bastide le Confort Medical S.A.

Bastide le Confort Medical is a holding company. Through its subsidiaries, Co. is engaged in the home health care industry. Co. retails and rents medical equipment and provides medical services. Products include breathing apparatus, orthopedic shoes, walking aids and wheelchairs, home appliances and furniture adapted to the needs of the lesser able, with the recent addition of equipment related to perfusion and nutrition. Co. operates through a number of outlets concentrated mainly in the South of France, offering advice and information to customers along with the provision and maintenance of medical equipment.
  • TickerBLC
  • ISINFR0000035370
  • ExchangeEuronext Paris
  • SectorHealth Care Equipment & Services
  • CountryFrance

Analysts

Christophe-Raphaël Ganet

Bastide : Q3 2019-2020 sales: improvement in home medical care business

>Organic growth of +5% - Q3 2018-19 sales totalled € 83.4m (+8.6% and +5% at constant scope).Management confirmed its 2018-19 sales target of € 335-340m, combined with an underlying operating margin of 8.5% over the full year. Bastide continues to examine external growth targets very selectively to rapidly strengthen its positions and market share.Halt in the contraction of home medical care for local authorities - Q3 growth is based on mome...

Christophe-Raphaël Ganet

Bastide : CA T3 2019/2020 : amélioration sur le MAD

>Organique à +5% - Le CA T3 se monte à 83.4 M€ (+8.6% et +5% à pc).Le management confirme son objectif de CA 2018-2019 situé entre 335 M€ et 340 M€, couplé à une MOp. courante de 8.5% sur l’exercice. Bastide continue d’étudier de manière sélective des cibles de croissance externes afin de renforcer rapidement ses positions et ses parts de marché.Arrêt de la baisse en MAD Collectivités - La croissance T3 s’appuie sur une dynamique de +5%, qui...

Alain William ...
  • Anis Zgaya
  • Aurelien Sivignon
  • Charles Lepetitpas
  • Christophe Chaput
  • Christophe-Raphaël Ganet
  • Emira Sagaama
  • Geoffroy Michalet
  • Hana Maalej
  • Hela Zarrouk
  • Jean Sassus
  • Jean-François Granjon
  • Jeremy Garnier
  • Jerôme Bodin
  • Khaled Ben Amor
  • Louis Boujard
  • Matthias Desmarais
  • Nicolas David
  • Nicolas Thorez
  • Philippe Ourpatian
  • Rémi Adam
  • Salma Bouraoui
  • Steven Gould

ODDO BHF Small & MIDCAP MORNING NEWS - 05/15/2019

...

Alain William ...
  • Anis Zgaya
  • Aurelien Sivignon
  • Charles Lepetitpas
  • Christophe Chaput
  • Christophe-Raphaël Ganet
  • Emira Sagaama
  • Geoffroy Michalet
  • Hana Maalej
  • Hela Zarrouk
  • Jean Sassus
  • Jean-François Granjon
  • Jeremy Garnier
  • Jerôme Bodin
  • Khaled Ben Amor
  • Louis Boujard
  • Matthias Desmarais
  • Nicolas David
  • Nicolas Thorez
  • Philippe Ourpatian
  • Rémi Adam
  • Salma Bouraoui
  • Steven Gould

ODDO BHF Small & MIDCAP MORNING NEWS - 15/05/2019

...

Christophe-Raphaël Ganet

Bastide : H1 2018-19 results: good level of margins, slight disappointment on cash – Guidance for the operating margin look cautious - Debt under control

>A good level of operating margin at 8.6% (vs 7.7% a year earlier) - H1 underlying operating profit was up 37.7%, to € 14.3m for net profit growth of “only” 22% to € 4.4m, impacted by i/ a number of non-recurring charges and an accounting adjustment for fair value for price supplements representing € 0.8m due to, amongst other things, an outperformance at Sphère Santé, ii/ a net loss of € 1.2m (the cancellation of a digitised patient management project, which is curre...

Christophe-Raphaël Ganet

Bastide : Q3 2019-2020 sales: improvement in home medical care business

>Organic growth of +5% - Q3 2018-19 sales totalled € 83.4m (+8.6% and +5% at constant scope).Management confirmed its 2018-19 sales target of € 335-340m, combined with an underlying operating margin of 8.5% over the full year. Bastide continues to examine external growth targets very selectively to rapidly strengthen its positions and market share.Halt in the contraction of home medical care for local authorities - Q3 growth is based on mome...

Christophe-Raphaël Ganet

Bastide : CA T3 2019/2020 : amélioration sur le MAD

>Organique à +5% - Le CA T3 se monte à 83.4 M€ (+8.6% et +5% à pc).Le management confirme son objectif de CA 2018-2019 situé entre 335 M€ et 340 M€, couplé à une MOp. courante de 8.5% sur l’exercice. Bastide continue d’étudier de manière sélective des cibles de croissance externes afin de renforcer rapidement ses positions et ses parts de marché.Arrêt de la baisse en MAD Collectivités - La croissance T3 s’appuie sur une dynamique de +5%, qui...

Alain William ...
  • Anis Zgaya
  • Aurelien Sivignon
  • Charles Lepetitpas
  • Christophe Chaput
  • Christophe-Raphaël Ganet
  • Emira Sagaama
  • Geoffroy Michalet
  • Hana Maalej
  • Hela Zarrouk
  • Jean Sassus
  • Jean-François Granjon
  • Jeremy Garnier
  • Jerôme Bodin
  • Khaled Ben Amor
  • Louis Boujard
  • Matthias Desmarais
  • Nicolas David
  • Nicolas Thorez
  • Philippe Ourpatian
  • Rémi Adam
  • Salma Bouraoui
  • Steven Gould

ODDO BHF Small & MIDCAP MORNING NEWS - 05/15/2019

...

Alain William ...
  • Anis Zgaya
  • Aurelien Sivignon
  • Charles Lepetitpas
  • Christophe Chaput
  • Christophe-Raphaël Ganet
  • Emira Sagaama
  • Geoffroy Michalet
  • Hana Maalej
  • Hela Zarrouk
  • Jean Sassus
  • Jean-François Granjon
  • Jeremy Garnier
  • Jerôme Bodin
  • Khaled Ben Amor
  • Louis Boujard
  • Matthias Desmarais
  • Nicolas David
  • Nicolas Thorez
  • Philippe Ourpatian
  • Rémi Adam
  • Salma Bouraoui
  • Steven Gould

ODDO BHF Small & MIDCAP MORNING NEWS - 15/05/2019

...

Christophe-Raphaël Ganet

Bastide : H1 2018-19 results: good level of margins, slight disappointment on cash – Guidance for the operating margin look cautious - Debt under control

>A good level of operating margin at 8.6% (vs 7.7% a year earlier) - H1 underlying operating profit was up 37.7%, to € 14.3m for net profit growth of “only” 22% to € 4.4m, impacted by i/ a number of non-recurring charges and an accounting adjustment for fair value for price supplements representing € 0.8m due to, amongst other things, an outperformance at Sphère Santé, ii/ a net loss of € 1.2m (the cancellation of a digitised patient management project, which is curre...

1 director bought

A director at Bastide Le Confort Medical bought 29,000 shares at 34.500EUR and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The...

Alain William ...
  • Charles Lepetitpas
  • Christophe Chaput
  • Christophe-Raphaël Ganet
  • Jean-François Granjon
  • Jeremy Garnier
  • Jerôme Bodin
  • Nicolas David
  • Stephane Houri

ODDO BHF Small & MIDCAP MORNING NEWS - 02/07/2019

...

Alain William ...
  • Charles Lepetitpas
  • Christophe Chaput
  • Christophe-Raphaël Ganet
  • Jean-François Granjon
  • Jeremy Garnier
  • Jerôme Bodin
  • Nicolas David
  • Stephane Houri

ODDO BHF Small & MIDCAP MORNING NEWS - 07/02/2019

...

Christophe Chaput ...
  • Christophe-Raphaël Ganet
  • Jeremy Garnier
  • Nicolas Thorez

ODDO BHF Small & MIDCAP MORNING NEWS - 01/10/2019

...

Christophe Chaput ...
  • Christophe-Raphaël Ganet
  • Jeremy Garnier
  • Nicolas Thorez

ODDO BHF Small & MIDCAP MORNING NEWS - 10/01/2019

...

Christophe-Raphaël Ganet ...
  • Emmanuel Matot

ODDO BHF Small & MIDCAP MORNING NEWS - 12/21/2018

...

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week...

Jehanne Leroy

Bastide Le Confort Médical - 03 Décembre 2018

Lors du dernier exercice, l’ensemble de l’équipe dirigeante, Directeur Général et Directeurs Généraux, a démissionné de leurs mandats sociaux. Suite à cela le Président du conseil, Guy Bastide, a repris les fonctions de direction, devenant ainsi Président Directeur Général de la société. Nous alertons, encore une fois, les actionnaires concernant la manque de transparence de la société dont elle fait preuve sur de nombreux éléments de son document de référence : tant concernant les conventions réglementées, que concernant sa politique de rémunération. Enfin il est proposé aux actionnaires de...

Charles Pinel

Etude de l'AG du 25/11/2016

Les dépenses non déductibles font l'objet d'une résolution spécifique. Elles ont augmenté très fortement lors des deux derniers exercices pour atteindre un montant de 233 356 € (+51%). Aucune justification n'est apportée par la société sur ce montant élevé ainsi que sur les évolutions entre chaque exercice malgré la demande effectuée par Proxinvest. Par conséquent, la résolution ne sera pas soutenue (résolution 3).Il est proposé aux actionnaires de constater que les conventions réglementées antérieurement conclues ont continué à produire leurs effets au cours de l'exercice écoulé. Parmi celles...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch